Literature DB >> 19407998

Clinical applications of PET amyloid imaging: an update.

Giovanni Lucignani1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19407998     DOI: 10.1007/s00259-009-1148-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  16 in total

1.  PET imaging of amyloid deposition in patients with mild cognitive impairment.

Authors:  Anton Forsberg; Henry Engler; Ove Almkvist; Gunnar Blomquist; Göran Hagman; Anders Wall; Anna Ringheim; Bengt Långström; Agneta Nordberg
Journal:  Neurobiol Aging       Date:  2007-05-11       Impact factor: 4.673

2.  Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Authors:  Jonghan Shin; Sang-Yoon Lee; So-Hee Kim; Young-Bo Kim; Seong-Jin Cho
Journal:  Neuroimage       Date:  2008-07-23       Impact factor: 6.556

Review 3.  The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Authors:  Victor L Villemagne; Michelle T Fodero-Tavoletti; Kerryn E Pike; Roberto Cappai; Colin L Masters; Christopher C Rowe
Journal:  Mol Neurobiol       Date:  2008-08-09       Impact factor: 5.590

4.  Imaging amyloid deposition in Lewy body diseases.

Authors:  S N Gomperts; D M Rentz; E Moran; J A Becker; J J Locascio; W E Klunk; C A Mathis; D R Elmaleh; T Shoup; A J Fischman; B T Hyman; J H Growdon; K A Johnson
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

5.  PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease.

Authors:  J Koivunen; A Verkkoniemi; S Aalto; A Paetau; J-P Ahonen; M Viitanen; K Någren; J Rokka; M Haaparanta; H Kalimo; J O Rinne
Journal:  Brain       Date:  2008-06-25       Impact factor: 13.501

6.  Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Authors:  Gary W Small; Prabha Siddarth; Alison C Burggren; Vladimir Kepe; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Paul M Thompson; Greg M Cole; S C Huang; Michael E Phelps; Susan Y Bookheimer; Jorge R Barrio
Journal:  Arch Gen Psychiatry       Date:  2009-01

7.  Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.

Authors:  Walter Maetzler; Inga Liepelt; Matthias Reimold; Gerald Reischl; Christoph Solbach; Clemens Becker; Claudia Schulte; Thomas Leyhe; Stefanie Keller; Arthur Melms; Thomas Gasser; Daniela Berg
Journal:  Neurobiol Dis       Date:  2008-12-31       Impact factor: 5.996

8.  Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.

Authors:  Meredith N Braskie; Andrea D Klunder; Kiralee M Hayashi; Hillary Protas; Vladimir Kepe; Karen J Miller; S-C Huang; Jorge R Barrio; Linda M Ercoli; Prabha Siddarth; Nagichettiar Satyamurthy; Jie Liu; Arthur W Toga; Susan Y Bookheimer; Gary W Small; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2008-11-11       Impact factor: 4.673

9.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11

10.  In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain.

Authors:  Liang Ye; Ana Velasco; Graham Fraser; Thomas G Beach; Lucia Sue; Tracy Osredkar; Vincenzo Libri; Maria Grazia Spillantini; Michel Goedert; Andrew Lockhart
Journal:  J Neurochem       Date:  2008-01-21       Impact factor: 5.372

View more
  1 in total

Review 1.  The prognostic value of amyloid imaging.

Authors:  Giorgio Gelosa; David J Brooks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-11       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.